PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33563204-0	2022	Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Inhibition of TGF-beta1/Smad3 and PI3K/AKT/mTOR Pathways.	Ticagrelor	0-10	AKT serine/threonine kinase 1	Rattus norvegicus	110-113	
33957564-11	2021	In conclusion, ticagrelor reno-therapeutic effect is partly mediated through modulating the Epac-1/Rap-1-GTP, AKT/Nrf-2/HO-1 and JAK-2/STAT-3/SOCS-3 trajectories, pathways that integrate to afford novel explanations to its anti-inflammatory, anti-oxidant, and anti-apoptotic potentials.	Ticagrelor	15-25	AKT serine/threonine kinase 1	Rattus norvegicus	110-113	
33563204-11	2022	In addition, ticagrelor antagonized PI3K/AKT/mTOR pathway signaling.	Ticagrelor	13-23	AKT serine/threonine kinase 1	Rattus norvegicus	41-44	
26044583-9	2015	Ticagrelor, but not clopidogrel, increased myocardial adenosine levels, increased phosphorylation of Akt, endothelial NO synthase, and extracellular-signal-regulated kinase 1/2 4 hours after reperfusion and decreased apoptosis.	Ticagrelor	0-10	AKT serine/threonine kinase 1	Rattus norvegicus	101-104